Hyderabad is rapidly becoming a global hub for pharmaceutical and biotech companies, with the addition of Eli Lilly and Merck (MSD) to its list of Global Capability Centers (GCCs). This development reinforces the city’s position as a leading destination for life sciences innovation and corporate expansion.
🔑 Key Highlights:
- Eli Lilly, the world’s No. 1 pharmaceutical company, has leased 2.1 lakh sqft at Phoenix Equinox in Hitec City, close to IKEA.
- Merck (MSD), ranked as the 5th largest pharmaceutical company globally, is also setting up its GCC in Hyderabad.
- Both companies are expected to commence operations by Q1/Q2 of 2025.
🌏 Current GCC Landscape in Hyderabad:
With these additions, Hyderabad now hosts GCCs for 9 of the world’s top 18 pharmaceutical, biotech, and medical device companies. Here’s the updated list:
- Novartis
- Sanofi
- Bristol Myers Squibb (BMS)
- Amgen
- Bayer
- Medtronic
- GSK (GlaxoSmithKline)
- Roche
- Eli Lilly and Company (new)
- Sandoz
This growth underscores Hyderabad’s strategic importance in the global pharma ecosystem, driven by its world-class infrastructure, talent pool, and business-friendly environment.